NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/10/2025
Voltar para busca
Dado oficial do USPTO
SHAREVAC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SHAREVAC
ST13
US500000098697887Classe
1, 5, 7, 9, 42, 44
Pedido
98697887
Registro
7972673
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
15
Atualização mais recente
08/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 7, 9, 42, 44
Data de depósito
14/08/2024
Data de registro
07/10/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/10/2025
Última transação
08/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Tubingen, DE
Examinador
SCHRADER,BRITTANY A
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
C. S. (pessoa física)
Representantes
Jennifer Fraser Dykema Gossett PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 7Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals and biomoleculesin particular biological macromoleculesfor industrial or scientific purposes; Reagents for research purposes
Classe 5
Chemical preparations for medical usein particular biological macromoleculesfor therapeutic and preventive treatment of tumor diseasesinfectious diseasesautoimmune disorders and allergiesfor treatment of inherited genetic diseases or for protein or enzyme replacement therapyfor treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor treatment of metabolic disorders; Pharmaceutical preparations namelyimmunostimulantsin particular for human or veterinary medical purposes; pharmaceutical preparationsvaccinesin particular for human or veterinary medical purposes; pharmaceutical preparationsadjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromoleculesin particular for human or veterinary purposes for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment of infectious diseasesautoimmune diseases and tumoursfor treatment of cancersfor treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; Pharmaceuticals preparations and medicines based on biological macromolecules for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment or prevention of infectious diseasesallergiesautoimmune disorders and tumour diseasesfor the treatment of metabolic disorders and for the treatment of inherited genetic diseases or for protein or enzyme replacement therapy; Gene therapeutic preparations being Nucleic acid macromolecules for in vivo or in vitro expression for human and veterinary use; Dietetic substances adapted for medical usein particular substances for food supplements; Vaccines
Classe 7
Bioreactors for use in manufacturing biopharmaceuticals; Filling machinesin particular for use for filling biopharmaceutical compositions into containers; Industry roboters being industrial robots
Classe 9
Scientific and laboratory apparatus for chemical synthesis; laboratory equipmentmobile laboratory equipped with scientific or laboratory apparatus for chemical synthesis; laboratory equipmentmobile laboratory equipped with scientific or laboratory apparatus for purification and analysis of synthesized compounds; laboratory equipmentmobile device for the synthesis of macromolecules; Scientific and laboratory apparatus for chemical or biological analysis and/or synthesis; laboratory equipmentmobile production station of biological macromolecules for laboratory or and for cell culturing for therapeutic use; Bioreactors for laboratory or and for cell culturing for therapeutic use
Classe 42
Scientific and technological servicesscientific researchin particular for identificationtesting and characterisation of biological molecules; scientific research in the nature of pre-clinical and clinical testing of macromolecules for others; Custom synthesis of chemical compoundsin particular biological macromolecules
Classe 44
Medical and veterinary servicesin particular for therapeutic and preventive treatment of tumour diseasesinfectious diseasesautoimmune disorders and allergiesfor the treatment of inherited genetic diseases or for protein or enzyme replacement therapyfor the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment of metabolic disorders; Vaccination services in the nature of administering vaccines to patients
Publicações
Histórico de despachos e eventos da marca no USPTO.
15 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
07/10/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/08/2025
PUBO
PUBLISHED FOR OPPOSITION
19/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2025
GNRT
NON-FINAL ACTION E-MAILED
04/03/2025
CNRT
NON-FINAL ACTION WRITTEN
04/03/2025
DOCK
ASSIGNED TO EXAMINER
20/02/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/01/2025
NWAP
NEW APPLICATION ENTERED
14/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SHAREVAC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.